Determinants of quality of life in Nigerian female patients with epilepsy on carbamazepine and levetiracetam monotherapy

Table 5 Showing logistic analysis of the correlates of QOLIE-TS

Variables	B	S.E	Wald	p-value	Odds ratio	95% CI
Variables	B					Lower Upper
Age
15–25	− 0.001	0.018	0.006	0.938	0.999	0.964 1.034
26–35	− 0.025	0.021	1.400	0.237	0.975	0.936 1.016
36–45	Reference
Medication
CBM	− 0.088	0.022	16.243	0.000*	0.915	0.877	0.956
LTM	Reference
EEG frequency
Fast	0.046	0.016	7.918	0.005*	1.047	1.014	1.081
Slow	Reference
Duration of epilepsy
< 2yrs	0.041	0.017	5.646	0.017*	1.042	1.007	1.077
≥ 2yrs	Reference
Depression
Present	− 0.054	0.020	7.138	0.008*	0.947	0.910	0.986
Absent	Reference
Highest level of education
Primary	− 0.127	0.042	9.006	0.003*	0.881	0.811	0.957
Secondary	− 0.114	0.041	7.735	0.005*	0.892	0.824	0.967
Tertiary	− 0.063	0.039	2.545	0.111	0.939	0.870	1.014
Postgraduate	Reference

B Beta co-efficient, S.E standard error, EEG electroencephalography, CI confidence interval, CBM carbamazepine, LTM levetiracetam
^*Statically significant